O46.01
Antepartum hemorrhage with afibrinogenemia
Clinical Classification Guidelines
Inclusion Terms
- Antepartum hemorrhage with hypofibrinogenemia
Medical Intelligence & Overview
Antepartum hemorrhage with afibrinogenemia is a rare but serious pregnancy complication characterized by bleeding from the genital tract before birth, combined with an abnormally low or absent level of fibrinogen, a vital protein for blood clotting. This condition requires prompt medical attention to manage bleeding risks and ensure the safety of both mother and baby.
Causes & Symptoms
Clinical Causes: Inherited or acquired disorders affecting fibrinogen production or function In obstetric complications that trigger abnormal bleeding responses Disseminated intravascular coagulation (DIC), a condition causing widespread clotting and bleeding Placental abruption or previa, leading to bleeding that strains clotting factors Liver diseases affecting fibrinogen synthesis Severe preeclampsia or eclampsia with compromised coagulation Other rare hematological disorders impacting coagulation pathways
Key Symptoms: Vaginal bleeding during the late stages of pregnancy Bleeding that may be heavy or difficult to control Signs of anemia, such as fatigue or pallor Potential signs of shock in severe cases (dizziness, rapid heartbeat) Possible abdominal pain or uterine tenderness depending on severity Laboratory evidence of low or absent fibrinogen levels Extended bleeding time and abnormal clotting profiles on tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Focused assessments include:
Treatment Protocols: Treating antepartum hemorrhage with afibrinogenemia involves multidisciplinary approaches aimed at controlling bleeding, correcting clotting deficiencies, and safeguarding fetal health. Core strategies include:
Clinical Advice & FAQs
Billing Guidance
Is O46.01 a billable ICD-10 code?
Yes, O46.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O46.01?
Clinical documentation must specify the nature of Antepartum hemorrhage with afibrinogenemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
